Repertoire of P-glycoprotein drug transporters in the zoonotic nematode Toxocara canis
- PMID: 36973306
- PMCID: PMC10042841
- DOI: 10.1038/s41598-023-31556-1
Repertoire of P-glycoprotein drug transporters in the zoonotic nematode Toxocara canis
Abstract
Toxocara canis has a complex lifecycle including larval stages in the somatic tissue of dogs that tolerate macrocyclic lactones. In this study, we investigated T. canis permeability glycoproteins (P-gps, ABCB1) with a putative role in drug tolerance. Motility experiments demonstrated that while ivermectin failed to abrogate larval movement, the combination of ivermectin and the P-gp inhibitor verapamil induced larval paralysis. Whole organism assays revealed functional P-gp activity in larvae which were capable of effluxing the P-gp substrate Hoechst 33342 (H33342). Further investigation of H33342 efflux demonstrated a unique rank order of potency for known mammalian P-gp inhibitors, suggesting that one or more of the T. canis transporters has nematode-specific pharmacological properties. Analysis of the T. canis draft genome resulted in the identification of 13 annotated P-gp genes, enabling revision of predicted gene names and identification of putative paralogs. Quantitative PCR was used to measure P-gp mRNA expression in adult worms, hatched larvae, and somatic larvae. At least 10 of the predicted genes were expressed in adults and hatched larvae, and at least 8 were expressed in somatic larvae. However, treatment of larvae with macrocyclic lactones failed to significantly increase P-gp expression as measured by qPCR. Further studies are needed to understand the role of individual P-gps with possible contributions to macrocyclic lactone tolerance in T. canis.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures








Similar articles
-
Transcriptional responses to in vitro macrocyclic lactone exposure in Toxocara canis larvae using RNA-seq.bioRxiv [Preprint]. 2024 Dec 20:2024.12.20.629602. doi: 10.1101/2024.12.20.629602. bioRxiv. 2024. PMID: 39763735 Free PMC article. Preprint.
-
Characterization of a P-glycoprotein drug transporter from Toxocara canis with a novel pharmacological profile.Int J Parasitol Drugs Drug Resist. 2021 Dec;17:191-203. doi: 10.1016/j.ijpddr.2021.10.002. Epub 2021 Oct 23. Int J Parasitol Drugs Drug Resist. 2021. PMID: 34753107 Free PMC article.
-
Effects of third generation P-glycoprotein inhibitors on the sensitivity of drug-resistant and -susceptible isolates of Haemonchus contortus to anthelmintics in vitro.Vet Parasitol. 2015 Jun 30;211(1-2):80-8. doi: 10.1016/j.vetpar.2015.04.025. Epub 2015 May 8. Vet Parasitol. 2015. PMID: 25986327
-
Toxocara canis: genes expressed by the arrested infective larval stage of a parasitic nematode.Int J Parasitol. 2000 Apr 10;30(4):495-508. doi: 10.1016/s0020-7519(00)00022-9. Int J Parasitol. 2000. PMID: 10731572 Review.
-
Potential roles of Toxocara canis larval excretory secretory molecules in immunomodulation and immune evasion.Acta Trop. 2023 Feb;238:106784. doi: 10.1016/j.actatropica.2022.106784. Epub 2022 Dec 9. Acta Trop. 2023. PMID: 36502886 Review.
Cited by
-
Transcriptional responses to in vitro macrocyclic lactone exposure in Toxocara canis larvae using RNA-seq.bioRxiv [Preprint]. 2024 Dec 20:2024.12.20.629602. doi: 10.1101/2024.12.20.629602. bioRxiv. 2024. PMID: 39763735 Free PMC article. Preprint.
-
Strain-level variations of Dirofilaria immitis microfilariae in two biochemical assays.PLoS One. 2024 Jul 17;19(7):e0307261. doi: 10.1371/journal.pone.0307261. eCollection 2024. PLoS One. 2024. PMID: 39018313 Free PMC article.
References
-
- Burke TM, Roberson EL. Fenbendazole treatment of pregnant bitches to reduce prenatal and lactogenic infections of Toxocara canis and Ancylostoma caninum in pups. J. Am. Vet. Med. Assoc. 1983;183(9):987–990. - PubMed
-
- Krämer F, Hammerstein R, Stoye M, Epe C. Investigations into the prevention of prenatal and lactogenic Toxocara canis infections in puppies by application of moxidectin to the pregnant dog. J. Vet. Med. B Infect. Dis. Vet. Public Health. 2006;53(5):218–223. doi: 10.1111/j.1439-0450.2006.00948.x. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous